SpyGlass Pharma, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from SpyGlass Pharma, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+11%Cash, after subtracting all debt, equals 11% of its market value (net cash).
Higher than 52% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
SpyGlass Pharma, Inc. made a loss over the last year. SpyGlass Pharma, Inc. owes $0.05 for every $1 it owns. SpyGlass Pharma, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossSpyGlass Pharma, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.06The share price is 4.06 times SpyGlass Pharma, Inc.'s book value per share, higher than 65% of Healthcare companies in United States.
Market cap
$944 MThe total market value of all of SpyGlass Pharma, Inc.'s shares at today's price (share price × number of shares), larger than 63% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$232 MWhat SpyGlass Pharma, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.95Net worth divided by the number of shares. The share price of $28.22 is 4.1 times this, which is the P/B above.
Owes vs Owns
0.05×SpyGlass Pharma, Inc. owes $0.05 for every $1 it owns (low), lower than 97% of Healthcare companies in United States.
Dividend yield
NoneSpyGlass Pharma, Inc. does not currently pay a dividend.
Profit growth
LossSpyGlass Pharma, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashSpyGlass Pharma, Inc. held $106 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For SpyGlass Pharma, Inc.: $944 M ÷ $232 M (30 Jun 2026) = 4.1.
How much does SpyGlass Pharma, Inc. owe compared with what it owns?
SpyGlass Pharma, Inc. owes $0.05 for every $1 it owns (low), lower than 97% of Healthcare companies in United States.
Does SpyGlass Pharma, Inc. pay a dividend?
No. SpyGlass Pharma, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.